Physician
Baig, Mirza
Baig, Mirza was paid $992K by Medicaid between Dec 2018 and Dec 2024, across 30 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 41% of everything it billed.
33Billing provider infoBAIG, MIRZA
ADDISON, IL 60101
ADDISON, IL 60101
33aNPI1679868707assigned 06/16/2011
33bProvider typeFamily Medicine Physician
28Total paid$992K
24GClaims22,859
24DCodes billed30
24AFirst – last monthDec 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Illinois
Rank by total paid#99 of 2,947
Median peer was paid$43K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13 | $887.67 | |
| 2021 | 260 | $9K | |
| 2022 | 4,677 | $186K | |
| 2023 | 9,537 | $386K | |
| 2024incomplete | 8,372 | $410K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 41% | 5,036 | 3,734 | $405K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 2,290 | 1,863 | $117K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 11% | 1,294 | 1,178 | $106K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7.8% | 2,246 | 1,912 | $77K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6.5% | 2,121 | 1,732 | $64K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.9% | 1,029 | 952 | $49K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.7% | 2,378 | 1,892 | $36K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.6% | 593 | 543 | $26K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.1% | 875 | 819 | $20K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.4% | 188 | 170 | $13K |
| 96160 | 1.3% | 911 | 784 | $13K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.3% | 1,071 | 798 | $13K |
18 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.2% | 87 | $12K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 71 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 88 | $4K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 51 | $4K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 116 | $4K |
| 87634 | <1% | 70 | $4K | |
| 87503 | <1% | 179 | $3K | |
| 94760 | <1% | 605 | $3K | |
| 96127 | <1% | 141 | $2K | |
| 99384 | <1% | 17 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 71 | $2K |
| 81001 | <1% | 557 | $2K | |
| 86580 | <1% | 263 | $1K | |
| 92551 | <1% | 78 | $1K | |
| 99173 | <1% | 142 | $1K | |
| 81002 | <1% | 252 | $645.90 | |
| 93000 | <1% | 27 | $552.60 | |
| 93042 | <1% | 12 | $48.69 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.